Renaissance Technologies LLC 13D and 13G filings for Acorda Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 12:35 pm Purchase | 2022-12-30 | 13G | Acorda Therapeutics, Inc. ACOR | Renaissance Technologies LLC | 43,445 3.570% | 7,737 (+21.67%) | Filing |
| 2022-02-11 2:20 pm Purchase | 2021-12-31 | 13G | Acorda Therapeutics, Inc. ACOR | Renaissance Technologies LLC | 35,708 6.380% | 35,708 (New Position) | Filing |